Advertisement

Squamous Cell Carcinoma

  • Marta Grazzini
  • Vincenzo De Giorgi
Chapter

Abstract

Malignant tumors of the epidermis are referred to as nonmelanoma skin cancer (NMSC). NMSC is the most frequent type of malignancy in humans and comprehends two major entities: squamous cell carcinoma (SCC) and basal cell carcinoma (BCC). SCC arises on sun-exposed areas of the skin and mucosa but they can also occur in covered parts of the body, particularly in patients that have other predisposing factors.

Abbreviations

5-FU

5-Fluorouracil

AK

Actinic keratosis

5-ALA

5-Aminolevulinic acid

AMM

Amelanotic malignant melanoma

BCC

Basal cell carcinoma

COX

Cyclooxygenase

EGFR

Epidermal growth factor receptor

NMSC

Nonmelanoma skin cancer

PDT

Photodynamic therapy

PpIX

Protoporphyrin IX

PUVA

Photochemotherapy

SCC

Squamous cell carcinoma

SK

Seborrheic keratosis

References

  1. Cranmer LD, Engelhardt C, Morgan SS. Treatment of unresectable and metastatic cutaneous squamous cell carcinoma. Oncologist. 2010;15(12):1320–8.PubMedPubMedCentralGoogle Scholar
  2. Gaffney DC, Soyer HP, Simpson F. The epidermal growth factor receptor in squamous cell carcinoma: an emerging drug target. Australas J Dermatol. 2013;​55:24–34.PubMedGoogle Scholar
  3. Hoogendijk-van den Akker JM, Harden PN, Hoitsma AJ, Proby CM, Wolterbeek R, Bouwes. Two-year randomized controlled prospective trial converting treatment of stable renal transplant recipients with cutaneous invasive squamous cell carcinomas to sirolimus. J Clin Oncol. 2013;31:1317–23.PubMedGoogle Scholar
  4. Sadek H, Azli N, Wendling JL, et al. Treatment of advanced squamous cell carcinoma of the skin with cisplatin, 5-fluorouracil, and bleomycin. Cancer. 1990;​66:1692–6.PubMedGoogle Scholar
  5. Zalaudek I, Giacomel J, Argenziano G, Hofmann-Wellenhof R, Micantonio T, Di Stefani A, Oliviero M, Rabinovitz H, Soyer HP, Peris K. Dermoscopy of facial nonpigmented actinic keratosis. Br J Dermatol. 2006;155(5):951–6.PubMedGoogle Scholar

Further Reading

  1. Alam M, Ratner D. Cutaneous squamous-cell carcinoma. N Engl J Med. 2001;344(13):975–83.PubMedGoogle Scholar
  2. Aldabagh B, Angeles JG, Cardones AR, Arron ST. Cutaneous squamous cell carcinoma and human papillomavirus: is there an association? Dermatol Surg. 2013;39:1–23.PubMedGoogle Scholar
  3. Berman B, Amini S. Pharmacotherapy of actinic keratosis: an update. Expert Opin Pharmacother. 2012;13(13):1847–71.PubMedGoogle Scholar
  4. Boukamp P. Non-melanoma skin cancer: what drives tumor development and progression? Carcinogenesis. 2005;26(10):1657–67.PubMedGoogle Scholar
  5. Cantisani C, De Gado F, Ulrich M, Bottoni U, Richetta AG, Calvieri S. Actinic keratosis: review of the literature and new patents. Recent Patents Inflamm Allergy Drug Discov. 2013;7:168–75.Google Scholar
  6. Grossman D, Leffell D. Squoamous cell carcinoma. Chapeter 114. Fitzpatrik’s dermatology in general medicine. Eight Edition. p 671–674Google Scholar
  7. Cherpelis BS, Marcusen C, Lang PG. Prognostic factors for metastasis in squamous cell carcinoma of the skin. Dermatol Surg. 2002;28:268–73.PubMedGoogle Scholar
  8. de Giorgi V, Alfaioli B, Papi F, Janowska A, Grazzini M, Lotti T, Massi D. Dermoscopy in pigmented squamous cell carcinoma. J Cutan Med Surg. 2009;13(6):326–9.PubMedGoogle Scholar
  9. DeConti RC. Chemotherapy of squamous cell carcinoma of the skin. Semin Oncol. 2012;39(2):145–9.PubMedGoogle Scholar
  10. Dirschka T, Radny P, Dominicus R, et al. Study groups. Long-term (6 and 12 months) follow-up of two prospective, randomized, controlled phase III trials of photodynamic therapy with BF-200 ALA and methyl aminolaevulinate for the treatment of actinic keratosis. Br J Dermatol. 2013;168(4):825–36.PubMedPubMedCentralGoogle Scholar
  11. Fargnoli MC, Kostaki D, Piccioni A, Micantonio T, Peris K. Dermoscopy in the diagnosis and management of non-melanoma skin cancers. Eur J Dermatol. 2012;22(4):456–63.PubMedGoogle Scholar
  12. Flohil SC, van der Leest RJ, Dowlatshahi EA, Hofman A, de Vries E, Nijsten T. Prevalence of actinic keratosis and its risk factors in the general population: the Rotterdam study. J Invest Dermatol. 2013;133:1971–8.PubMedGoogle Scholar
  13. Gallagher RP, Hill GB, Bajdik CD, et al. Sunlight exposure, pigmentation factors, and risk of nonmelanocytic skin cancer. II. Squamous cell carcinoma. Arch Dermatol. 1995;131:164–9.PubMedGoogle Scholar
  14. Goldberg LH, Kaplan B, Vergilis-Kalner I, Landau J. Liquid nitrogen: temperature control in the treatment of actinic keratosis. Dermatol Surg. 2010;36(12):1956–61.PubMedGoogle Scholar
  15. Gray DT, Suman VJ, Su WP, Clay RP, Harmsen WS, Roenigk RK. Trends in the population-based incidence of squamous cell carcinoma of the skin first diagnosed between 1984 and 1992. Arch Dermatol. 1997;133:735–40.PubMedGoogle Scholar
  16. Grazzini M, Stanganelli I, Rossari S, Gori A, Oranges T, Longo AS, Lotti T, Bencini PL, De Giorgi V. Dermoscopy, confocal laser microscopy, and hi-tech evaluation of vascular skin lesions: diagnostic and therapeutic perspectives. Dermatol Ther. 2012;25(4):297–303.PubMedGoogle Scholar
  17. Guidelines of care for cutaneous squamous cell carcinoma: committee on guidelines of care, task force on cutaneous squamous cell carcino- ma. J Am Acad Dermatol. 1993;28:628–31.Google Scholar
  18. Johnson TM, Rowe DE, Nelson BR, Swanson NA. Squamous cell carcinoma of the skin (excluding lip and oral mucosa). J Am Acad Dermatol. 1992;26:467–84.PubMedGoogle Scholar
  19. Khan MH, Alam M, Yoo S. Epidermal growth factor receptor inhibitors in the treatment of nonmelanoma skin cancers. Dermatol Surg. 2011;37(9):1199–209.PubMedGoogle Scholar
  20. Lomas A, Leonardi-Bee J, Bath-Hextall F. A systematic review of worldwide incidence of nonmelanoma skin cancer. Br J Dermatol. 2012;166:1069–80.PubMedGoogle Scholar
  21. Martin GM, Stockfleth E. Diclofenac sodium 3 % gel for the management of actinic keratosis: 10+ years of cumulative evidence of efficacy and safety. Drugs Dermatol. 2012;11(5):600–8.Google Scholar
  22. Minton TJ. Contemporary Mohs surgery applications. Curr Opin Otolaryngol Head Neck Surg. 2008;16:376–80.PubMedGoogle Scholar
  23. Muellenhoff MW, Koo JY. Cyclosporine and skin cancer: an international dermatologic perspective over 25 years of experience. A comprehensive review and pursuit to define safe use of cyclosporine in dermatology. J Dermatol Treat. 2012;23(4):290–304.Google Scholar
  24. Pons M, Quintanilla M. Molecular biology of malignant melanoma and other cutaneous tumors. Clin Transl Oncol. 2006;8(7):466–74.PubMedGoogle Scholar
  25. Ratushny V, Gober MD, Hick R, Ridky TW, Seykora JT. From keratinocyte to cancer: the pathogenesis and modeling of cutaneous squamous cell carcinoma. J Clin Invest. 2012;122(2):464–72.PubMedPubMedCentralGoogle Scholar
  26. Rosendahl C, Cameron A, Argenziano G, Zalaudek I, Tschandl P, Kittler H. Dermoscopy of squamous cell carcinoma and keratoacanthoma. Arch Dermatol. 2012;148(12):1386–92.PubMedGoogle Scholar
  27. Rudolph R, Zelac D. Squamous cell carcinoma of the skin. Plast Reconstr Surg. 2004;114:82–94.Google Scholar
  28. Salasche S. Epidemiology of actinic keratoses and squamous cell carcinoma. J Am Acad Dermatol. 2000;42:4–7.PubMedGoogle Scholar
  29. Schwartz RA. Keratoacanthoma. J Am Acad Dermatol. 1994;30:1–22.PubMedGoogle Scholar
  30. Stern RS. PUVA follow-up study. The risk of squamous cell and basal cell cancer associated with psoralen and ultraviolet A therapy: a 30-year prospective study. J Am Acad Dermatol. 2012;66(4):553–6.PubMedGoogle Scholar
  31. Stough D, Bucko AD, Vamvakias G, Rafal ES, Davis SA. Fluorouracil cream 0.5 % for actinic keratoses on multiple body sites: an 18-month open-label study. Cutis. 2010;85(5):267–73.PubMedGoogle Scholar
  32. Strohal R, Kerl H, Schuster L. Treatment of actinic keratoses with 5 % topical imiquimod: a multicenter prospective observational study from 93 Austrian office-based dermatologists. J Drugs Dermatol. 2012;11(5):574–8.PubMedGoogle Scholar
  33. Terushkin V, Braga JC, Dusza SW, Scope A, Busam K, Marghoob AA, Gill M, Halpern AC. Agreement on the clinical diagnosis and management of cutaneous squamous neoplasms. Dermatol Surg. 2010;36(10):1514–20.PubMedGoogle Scholar
  34. Wehner MR, Shive ML, Chren MM, Han J, Qureshi AA, Linos E. Indoor tanning and non-melanoma skin cancer: systematic review and meta-analysis. BMJ. 2012;345:e5909.PubMedPubMedCentralGoogle Scholar
  35. Zalaudek I, Kreusch J, Giacomel J, Ferrara G, Catricalà C, Argenziano G. How to diagnose nonpigmented skin tumors: a review of vascular structures seen with dermoscopy: part II. Nonmelanocytic skin tumors. J Am Acad Dermatol. 2010;63(3):377–86.PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2015

Authors and Affiliations

  • Marta Grazzini
    • 1
  • Vincenzo De Giorgi
    • 1
  1. 1.Division of Dermatology, Department of Surgery and Translational MedicineUniversity of FlorenceFlorenceItaly

Personalised recommendations